GlassScriptPhysician profile
Jay Won Bartlett
NPI 1689932113
$3,217.29
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,512 · 2022: $1,509 · 2023: $124 · 2024: $71.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $527.14 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $519.72 | 2021-2023 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $495.27 | 2021-2022 | |
| Optinose US, INC. | $391.64 | 2021-2023 | |
| Glaxosmithkline, LLC. | $348.19 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $192.26 | 2021-2022 | |
| Kaleo, INC. | $174.02 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $124.75 | 2021-2022 | |
| Biocryst US Sales Co., LLC | $119.40 | 2021-2023 | Orladeyo |
| Teva Pharmaceuticals USA, INC. | $83.54 | 2021-2022 | |
| Abbvie INC. | $71.74 | 2024 | |
| Genentech USA, INC. | $44.17 | 2021-2022 | |
| Alk-Abello, INC | $32.94 | 2022 | |
| Pfizer INC. | $29.59 | 2021 | |
| Sanofi-Aventis U.S. LLC | $24.49 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $20.64 | 2021 | |
| Amgen INC. | $17.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Won Bartlett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.